Endothelial damage in patients with asthma and co-morbid coronary heart disease
https://doi.org/10.18093/0869-0189-2017-27-4-490-495
Abstract
Recently, growing number of patients with bronchial asthma (BA) and co-morbid cardiovascular diseases has been noted. The purpose of this study was to investigate a relationship between markers of endothelial dysfunction and parameters of arterial stiffness in patients with BA and stable class 1 to 3 angina pectoris. Methods. We examined 32 BA patients 32 patients with co-morbidity of BA and ischemic heart disease (IHD). Results. Arterial stiffness was increased in BA patients. Co-morbidity of BA and IHD resulted in more prominent increase in the arterial stiffness and endothelial dysfunction. Conclusion. Diagnosis IHD in BA patients is quite difficult in clinical practice. Markers of this co-morbidity are needed to improve the diagnostic work-up.
About the Authors
Y. I. VerigoRussian Federation
Postgraduate student, Department No.2 of Internal Medicine and Postgraduate Physician Training Course,
ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022
I. V. Demko
Russian Federation
Doctor of Medicine, Professor, Head of Department No.2 of Internal Medicine and Postgraduate Physician Training Course, ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022;
Head of Center of Pulmonology and Allergology, ul. Partizana Zheleznyaka 3, Krasnoyarsk, 660022
Competing Interests:
д. м. н., профессор, заведующая кафедрой внутренних болезней № 2 с курсом постдипломного образования, Красноярск, ул. Партизана Железняка, 1;
заведующая легочно-аллергологическим центром, 660022, Красноярск, ул. Партизана Железняка, 3
M. M. Petrova
Russian Federation
Doctor of Medicine, Professor, Head of Department of Outpatient Therapy, Family Medicine and Healthy Lifestyle with Postgraduate Physician Training Course,
ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022
E. A. Sobko
Russian Federation
Doctor of Medicine, Associate Professor at Department No.2 of Internal Medicine and Postgraduate Physician Training Course, ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022;
Head of Division of Pulmonology and Allergology, Center of Pulmonology and Allergology, ul. Partizana Zheleznyaka 3, Krasnoyarsk, 660022
A. E. Ryazanov
Russian Federation
a cardiologist,
ul. Partizana Zheleznyaka 3, Krasnoyarsk, 660022
References
1. Global Strategy for Diagnosis, Management, and Prevention of COPD. Updated 2011.Translated from English (edited by A.S.Belevskiy). Moscow: Rossiyskoe respiratornoe obshchestvo; 2012 (in Russian).
2. Mahfouz R.A., El-dawei K., El-Dosoky I., Hamzah M. The impact of the eNOS Glu298→Asp polymorphisms on endothelial and diastolic function in non-diabetic offspring of diabetic parents. J. Med. Diagn. Meth. 2015; S2-003. DOI: 10.4172/2168-9784.S2-003.
3. Demko I.V., Gordeeva N.V., Petrova M. et al. Clinical signs and treatment of asthma and co-morbid cardiovascular diseases. Byulleten' sibirskoy meditsiny. 2007; (2): 90–97 (in Russian).
4. Iribarren C.,Tolstykh I.V., Miller M.K. et al. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failture: a prospective study of 2 matched cohorts. Am. J. Epidemiol. 2012; 176 (11): 1014–1024. DOI: 10.1093/aje/kws181.
5. Zagidullin N.Sh., Valaeva K.F., Gassanov N. et al. A role of endothelial dysfunction in cardiovascular diseases and its pharmacological correction. Kardiologiya. 2010; 50 (5): 54–60 (in Russian).
6. Sobko E.A., Kraposhina A.Yu., Demko I.V. A role of CD38 for development of endothelial dysfunction in patients with asthma. Vestnik sovremennoy klinicheskoy meditsiny. 2010; (2): 112–117 (in Russian).
7. Gutierrez E., Flammer A.J., Lerman L.O. et al. Endothelial dysfunction over the course of coronary artery disease. Eur. Heart J. 2013; 34 (41): 3175–3181. DOI: 10.1093/eurheartj/eht351.
8. Choi B.J., Prasad A., Gulati R. et al. Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur. Heart J. 2013; 34 (27): 2047–2054. DOI: 10.1093/eurheartj/eht132.
9. Budovskaya L.A. Inflammation mechanisms in co-morbidity of asthma and ischaemic heart disease. Ukrainskiy pul'monologicheskiy zhurnal. 2012; (1): 68–72 (in Russian).
10. Tereshchenko S.N., Zhirov I.V., Malichenko E.V. Comparison of angiotensin-converting enzyme inhibitors ramipril and enalapril in therapy of female patients with chronic heart failure. Kardiologiya. 2010; (4): 64–68 (in Russian).
11. Galyautdinov G.S., Chudakova E.A. Hemostasis features in patients with ischaemic heart disease. Kazanskiy meditsinskiy zhurnal. 2012; 93 (1): 3–7 (in Russian).
12. Tadtaeva N.E., Basieva O.O. Coagulation factors as markers of endothelial dysfunction in patients with type 2 diabetes mellitus and hypertension. Vestnik ural'skoy meditsinskoy akademicheskoy nauki. 2014; (1): 32–34 (in Russian).
13. Schultz M.G., Hughes A.D., Davies J. et al. Associations and clinical relevance of aortic-brachial artery stiffness mismatch, aortic reservoir function and central pressure augmentation. Am. J. Physiol. Heart Circ. Physiol. 2015; 309 (7): H1225–H1233. DOI: 10.1152/ajpheart.00317.2015.
14. Inzhutova A.I., Larionov A.A., Salmina A.B. et al. Molecular mechanisms of endothelial dysfunction of various etiologies (the 1st report). Sibirskiy meditsinskiy zhurnal (Irkutsk). 2010; 96 (5): 85–88 (in Russian).
15. Gel'tser B.I., Brodskaya T.A., Nevzorova V.A. Functional tests for assessment of arterial stiffness in patients with asthma . Pul'monologiya. 2008; (2): 42–46 (in Russian).
Review
For citations:
Verigo Y.I., Demko I.V., Petrova M.M., Sobko E.A., Ryazanov A.E. Endothelial damage in patients with asthma and co-morbid coronary heart disease. PULMONOLOGIYA. 2017;27(4):490-495. (In Russ.) https://doi.org/10.18093/0869-0189-2017-27-4-490-495